Translate

Τρίτη 18 Αυγούστου 2020

 

Gastric Cancer Heterogeneity and Clinical Outcomes
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Gastric adenocarcinoma is a highly aggressive disease with poor overall survival. The aggressive nature of this disease is in part due to the high intra and inter tumoral heterogeneity and also due to the late diagnosis at presentation. Once progression occurs, treatment is more difficult due to the adaptation of tumors, which acquires resistance to commonly used chemotherapeutics. In this report, using publicly...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 14:14
Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:The present study aimed to explore the correlation of protein kinase D 1 with prognosis in bortezomib-treated multiple myeloma patients and further investigate the effect of protein kinase D 1 knockdown on drug sensitivity to bortezomib in multiple myeloma cells.Methods:Totally, 104 de novo symptomatic multiple myeloma patients treated with bortezomib-based regimens and 30 healthy controls were recruited....
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:05
Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:The present study aimed to detect A-kinase interacting protein 1 expression and further explore the association of A-kinase interacting protein 1 with clinical features and prognosis in patients with multiple myeloma.Methods:Totally, 152 de novo symptomatic patients with multiple myeloma and 30 healthy donors were enrolled. Bone marrow mononuclear cells derived plasma cells were collected from patients...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:05
MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Background/Aims:Nasopharyngeal carcinoma is a common head and neck cancer in South China and Southeast Asia. Radiotherapy is the standard treatment for nasopharyngeal carcinoma. Accumulating evidence showed that the expression of miR-34a was abnormal in nasopharyngeal carcinoma. Here, this study investigates the effect of miR-34a on radiosensitivity of nasopharyngeal carcinoma cells and explored the underlying...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:04
Automatic Segmentation of the Gross Target Volume in Non-Small Cell Lung Cancer Using a Modified Version of ResNet
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Radiotherapy plays an important role in the treatment of non-small cell lung cancer. Accurate segmentation of the gross target volume is very important for successful radiotherapy delivery. Deep learning techniques can obtain fast and accurate segmentation, which is independent of experts’ experience and saves time compared with manual delineation. In this paper, we introduce a modified version of ResNet and apply...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:00
Changes in Pulmonary Function After 3 Surgical Methods of Pulmonary Nodules Resection by Uniportal Video-Assisted Thoracoscopic Surgery
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:The purpose of this study was to evaluate the changes in pulmonary function after wedge resection, segmentectomy, and lobectomy.Methods:The patients were divided into 4 groups: lobectomy group, segmentectomy group, wedge resection group, and mediastinal surgery group. The pulmonary function was evaluated at various time points: 3 days before surgery, 1 month, 6 months, 12 months, and then 24 months after...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:00
SKA3 Promotes Cell Growth in Breast Cancer by Inhibiting PLK-1 Protein Degradation
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Breast cancer (Bca) remains the most common form of malignancy affecting females in China, leading to significant reductions in the mental and physical health of those with this condition. While spindle and kinetochore associated complex subunit 3 (SKA3) is known to be linked with cervical cancer progression, whether it is similarly associated with Bca progression remains unknown. Using shRNA, we specifically...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:00
Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Hepatocellular carcinoma (HCC) remains to a common cause of tumor mortality worldwide and represents the most common type of lethal hepatic malignancy. The incidence of HCC is swiftly increasing in western countries and southeast Asia. Despite poor prognosis, traditional treatments for advanced HCC appear to be minimally effective or even useless since patients are usually diagnosed in the advanced stage of disease....
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:00
Long Noncoding RNA Plasmacytoma Variant Translocation 1 Is Increased in Multiple Myeloma and Correlates With Lower Induction Response
Technology in Cancer Research &Treatment, Volume 19, Issue , January-December 2020. Objective:This study aimed to investigate the correlation of long noncoding RNA plasmacytoma variant translocation 1 with clinical features and prognosis in patients with multiple myeloma.Methods:The bone marrow samples were collected from 128 patients with de novo symptomatic multiple myeloma (before initial treatment) and 30 healthy donors (on the enrollment). Long noncoding RNA plasmacytoma variant translocation...
SAGE Publications Inc: Technology in Cancer Research & Treatment: Table of Contents
Mon Aug 17, 2020 13:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate